Investors Sell Shares of Humana Inc. (HUM) on Strength (HUM)
Investors sold shares of Humana Inc. (NYSE:HUM) on strength during trading hours on Friday. $31.37 million flowed into the stock on the tick-up and $84.13 million flowed out of the stock on the tick-down, for a money net flow of $52.76 million out of the stock. Of all equities tracked, Humana had the 10th highest net out-flow for the day. Humana traded up $0.03 for the day and closed at $256.56
Several equities analysts have weighed in on the company. ValuEngine raised Humana from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. UBS AG reiterated a “neutral” rating and set a $250.00 price target (up from $237.00) on shares of Humana in a report on Wednesday, August 9th. BidaskClub upgraded Humana from a “sell” rating to a “hold” rating in a report on Thursday, August 10th. Cantor Fitzgerald reiterated a “neutral” rating and set a $223.00 price target (up from $200.00) on shares of Humana in a report on Thursday, August 3rd. Finally, Morgan Stanley lifted their price target on Humana from $269.00 to $276.00 and gave the company an “overweight” rating in a report on Thursday, August 17th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the stock. Humana currently has a consensus rating of “Buy” and an average target price of $244.35.
The firm has a market capitalization of $37.08 billion, a P/E ratio of 21.11 and a beta of 0.87. The company has a 50-day moving average price of $247.05 and a 200 day moving average price of $229.66.
Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The company had revenue of $13.53 billion during the quarter, compared to analysts’ expectations of $13.61 billion. During the same period last year, the firm posted $2.30 earnings per share. Equities research analysts anticipate that Humana Inc. will post $11.55 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Tuesday, August 29th will be given a $0.40 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.62%. Humana’s payout ratio is 13.06%.
In other news, insider William Kevin Fleming sold 3,071 shares of the firm’s stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $250.98, for a total value of $770,759.58. Following the completion of the sale, the insider now directly owns 7,681 shares of the company’s stock, valued at $1,927,777.38. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP M Todoroff Christopher sold 22,935 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The shares were sold at an average price of $252.52, for a total value of $5,791,546.20. Following the completion of the sale, the vice president now directly owns 24,001 shares of the company’s stock, valued at $6,060,732.52. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 60,566 shares of company stock valued at $15,326,746. Insiders own 0.80% of the company’s stock.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Guardian Life Insurance Co. of America lifted its position in shares of Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after buying an additional 4 shares during the last quarter. Reliance Trust Co. of Delaware lifted its position in shares of Humana by 0.7% in the second quarter. Reliance Trust Co. of Delaware now owns 1,123 shares of the insurance provider’s stock valued at $270,000 after buying an additional 8 shares during the last quarter. Creative Planning lifted its position in shares of Humana by 0.3% in the second quarter. Creative Planning now owns 4,874 shares of the insurance provider’s stock valued at $1,173,000 after buying an additional 15 shares during the last quarter. WFG Advisors LP lifted its position in shares of Humana by 4.5% in the second quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock valued at $113,000 after buying an additional 20 shares during the last quarter. Finally, Cadence Capital Management LLC lifted its position in shares of Humana by 0.4% in the second quarter. Cadence Capital Management LLC now owns 5,682 shares of the insurance provider’s stock valued at $1,367,000 after buying an additional 22 shares during the last quarter. 95.14% of the stock is owned by institutional investors.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.